Form D · Biotechnology
Biotix Holdings Inc.
San Diego, CA · CIK 0001517218
Offering snapshot reported Apr 20, 2012 · SEC filing
- Reported sold
- $2.2M Offering amount: $2.35M
- Investors reported
- 9 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 6, 2012 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 20, 2012 | Initial | $2,195,000 | No comparison | 9 | SEC filing |
| Apr 1, 2011 | Initial | $2,000,000 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-177055
Source: Form D, filed Apr 20, 2012. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Anthony Altig | Executive |
| Charles P. Cullen | Director |
| Lawson De Vries | Director |
| David A. Freeman | Director |
| Ryan Kirkpatrick | Director |
| Paul J. Nowak | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
9880 Mesa Rim Road
San Diego, CA, 92121
San Diego, CA, 92121